Addressing diversity gaps in esketamine clinical trials: a registry-based cross-sectional analysis of sex, race and ethnicity
Esketamine clinical trials demonstrate significant racial and ethnic disparities, with underrepresentation of racial and ethnic minority groups. Regulatory efforts to improve diversity must lead to more effective recruitment for fair representation in future research.
Authors
- Damian Świeczkowski (ORCID: https://orcid.org/0000-0002-5648-4652)
- Wiesław Jerzy Cubała (ORCID: https://orcid.org/0000-0001-6343-8454)
- Aleksander Kwaśny
- Prof Lukasz Szarpak
- Michal Pruc
Institutions
- John Paul II Catholic University of Lublin (PL)
- Ben Taub Hospital (US)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- International Journal of Psychiatry in Clinical Practice
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1080/13651501.2026.2622532
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00